Literature DB >> 22428977

Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.

Christine Aurnhammer1, Maren Haase, Nadine Muether, Martin Hausl, Christina Rauschhuber, Ingrid Huber, Hans Nitschko, Ulrich Busch, Andreas Sing, Anja Ehrhardt, Armin Baiker.   

Abstract

Viral vectors based on various naturally occurring adeno-associated virus (AAV) serotypes are among the most promising tools in human gene therapy. For the production of recombinant AAV (rAAV) vectors, researchers are focusing predominantly on cross-packaging an artificial AAV genome based on serotype 2 (AAV2) into capsids derived from other serotypes. Within the packaged genome the inverted terminal repeats (ITRs) are the only cis-acting viral elements required for rAAV vector generation and depict the lowest common denominator of all AAV2-derived vector genomes. Up to now, no quantitative PCR (qPCR) for the detection and quantification of AAV2 ITRs could be established because of their extensive secondary hairpin structure formation. Current qPCR-based methods are therefore targeting vector-encoded transgenes or regulatory elements. Herein we establish a molecular biological method that allows accurate and reproducible quantification of AAV2 genomes on the basis of an AAV2 ITR sequence-specific qPCR. Primers and labeled probe are located within the ITR sequence and have been designed to detect both wild-type AAV2 and AAV2-based vectors. This method is suitable for detecting single-stranded DNA derived from AAV2 vector particles and double-stranded DNA derived from vector plasmids. The limit of detection has been determined as 50 ITR sequence copies per reaction, by comparison with a plasmid standard. In conclusion, this method describes the first qPCR system facilitating the detection and quantification of AAV2 ITR sequences. Because this method can be used universally for all AAV2 genome-based vectors, it will significantly simplify rAAV2 vector titrations in the future.

Entities:  

Mesh:

Year:  2012        PMID: 22428977     DOI: 10.1089/hgtb.2011.034

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  148 in total

1.  Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.

Authors:  Ophélie Vacca; Brahim El Mathari; Marie Darche; José-Alain Sahel; Alvaro Rendon; Deniz Dalkara
Journal:  J Vis Exp       Date:  2015-04-19       Impact factor: 1.355

2.  Dentate Gyrus Contributes to Retrieval as well as Encoding: Evidence from Context Fear Conditioning, Recall, and Extinction.

Authors:  Brian E Bernier; Anthony F Lacagnina; Adam Ayoub; Francis Shue; Boris V Zemelman; Franklin B Krasne; Michael R Drew
Journal:  J Neurosci       Date:  2017-05-25       Impact factor: 6.167

3.  Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells.

Authors:  M Kyle Cromer; Sriram Vaidyanathan; Daniel E Ryan; Bo Curry; Anne Bergstrom Lucas; Joab Camarena; Milan Kaushik; Sarah R Hay; Renata M Martin; Israel Steinfeld; Rasmus O Bak; Daniel P Dever; Ayal Hendel; Laurakay Bruhn; Matthew H Porteus
Journal:  Mol Ther       Date:  2018-07-11       Impact factor: 11.454

4.  Quantification of Adeno-Associated Virus with Safe Nucleic Acid Dyes.

Authors:  Jian Xu; Steven H DeVries; Yongling Zhu
Journal:  Hum Gene Ther       Date:  2020-07-14       Impact factor: 5.695

5.  Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.

Authors:  Yuan Wang; Chen Ling; Liujiang Song; Lina Wang; George V Aslanidi; Mengqun Tan; Changquan Ling; Arun Srivastava
Journal:  Hum Gene Ther Methods       Date:  2012-08       Impact factor: 2.396

6.  CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.

Authors:  Rasmus O Bak; Matthew H Porteus
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

7.  Fragile X Mental Retardation Protein Bidirectionally Controls Dendritic Ih in a Cell Type-Specific Manner between Mouse Hippocampus and Prefrontal Cortex.

Authors:  Federico Brandalise; Brian E Kalmbach; Preeti Mehta; Olivia Thornton; Daniel Johnston; Boris V Zemelman; Darrin H Brager
Journal:  J Neurosci       Date:  2020-05-28       Impact factor: 6.167

8.  Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.

Authors:  Dwaipayan Sen; Rupali A Gadkari; Govindarajan Sudha; Nishanth Gabriel; Yesupatham Sathish Kumar; Ruchita Selot; Rekha Samuel; Sumathi Rajalingam; V Ramya; Sukesh C Nair; Narayanaswamy Srinivasan; Alok Srivastava; Giridhara R Jayandharan
Journal:  Hum Gene Ther Methods       Date:  2013-04       Impact factor: 2.396

9.  CRISPR/Cas9 genome editing in human hematopoietic stem cells.

Authors:  Rasmus O Bak; Daniel P Dever; Matthew H Porteus
Journal:  Nat Protoc       Date:  2018-01-25       Impact factor: 13.491

10.  High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k "Helper" Proteins.

Authors:  Kamila S Gwiazda; Alexandra E Grier; Jaya Sahni; Stephen M Burleigh; Unja Martin; Julia G Yang; Nicholas A Popp; Michelle C Krutein; Iram F Khan; Kyle Jacoby; Michael C Jensen; David J Rawlings; Andrew M Scharenberg
Journal:  Mol Ther       Date:  2016-05-16       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.